CHI ASIA VALLEY (01272) announced its interim results, with a profit attributable to shareholders of 286 million yuan, an increase of 0.91% year-on-year.
The Central Asia Xingu Group (01272) announced its results for the six months ending June 30, 2026, during which the group achieved revenue of 2.259 billion yuan, a decrease of 6.2% year-on-year; profit attributable to the owners of the parent company was 286 million yuan, an increase of 0.91% year-on-year; basic earnings per share were 0.1 yuan.
CHI ASIA VALLEY (01272) announced its results for the six months ended June 30, 2026, during which the group achieved revenue of RMB 2.259 billion, a year-on-year decrease of 6.2%; profit attributable to equity shareholders of the parent company was RMB 286 million, a year-on-year increase of 0.91%; basic earnings per share were RMB 0.1.
Related Articles

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

RECOMMEND





